Reactive jet impingement bioprinting of high cell density gels for bone microtissue fabrication
Source abstract
Abstract
Abstract Advances in three-dimensional cell cultures offer new opportunities in biomedical research and drug development. However, there are still challenges to overcome, including the lack of reliability, repeatability and complexity of tissues obtained by these techniques. In this study, we describe a new bioprinting system called reactive jet impingement (ReJI) for the bioprinting of cell-laden hydrogels. Droplets of gel precursor solutions are jetted at one another such that they meet and react in mid-air before the gel droplets fall to the substrate. This technique offers a combination of deposition rate, cell density and cell viability which is not currently matched by any other bioprinting technique. The importance of cell density is demonstrated in the development of bone microtissues derived from immortalised human bone marrow stem cells. The cells were printed with high viability within a collagen-alginate-fibrin gel, and tissue specific gene expression shows significantly higher tissue maturation rates using the ability of the ReJI system to deposit gels with a high cell density.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Spaceflight effects on biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. The third dimension bridges the gap between cell culture and live tissue10.1038/nrm2236 ↗
2. Metabolic profiling of healthy and cancerous tissues in 2D and 3D10.1038/s41598-017-15325-5 ↗
3. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors10.1089/adt.2014.573 ↗
4. Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery10.1038/srep28951 ↗
5. From 3D cell culture to organs-on-chips10.1016/j.tcb.2011.09.005 ↗
6. Organoids10.1038/nmeth.4576 ↗
7. The Microwell-mesh: a high-throughput 3D prostate cancer spheroid and drug-testing platform10.1038/s41598-017-18050-1 ↗
8. Biomaterials-based approaches to tumor spheroid and organoid modeling10.1002/adhm.201700980 ↗
9. Toward modeling the bone marrow niche using scaffold-based 3D culture systems10.1016/j.biomaterials.2010.09.041 ↗
10. 3D cell culture systems modeling tumor growth determinants in cancer target discovery10.1016/j.addr.2014.03.001 ↗
11. Three-dimensional cell culture: the missing link in drug discovery10.1016/j.drudis.2012.10.003 ↗
12. A reliable tool to determine cell viability in complex 3D culture: the acid phosphatase assay10.1177/1087057107306839 ↗
13. Microfluidic 3D cell culture: from tools to tissue models10.1016/j.copbio.2015.05.002 ↗
14. An end-user perspective on organ-on-a-chip: assays and usability aspects10.1016/j.cobme.2017.02.002 ↗
15. Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D10.1088/1758-5090/7/4/044102 ↗
16. Deterministically patterned biomimetic human iPSCderived hepatic model via rapid 3D bioprinting10.1073/pnas.1524510113 ↗
17. 3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: an in vitro evaluation of biomimetic mechanical property and cell growth environment10.1016/j.actbio.2016.12.008 ↗
18. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity10.1038/nbt.3413 ↗
19. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
20. Bio-inks for 3D bioprinting: recent advances and future prospects10.1039/C7PY00826K ↗
21. Current advances and future perspectives in extrusion-based bioprinting10.1016/j.biomaterials.2015.10.076 ↗
22. Scaffold-free vascular tissue engineering using bioprinting10.1016/j.biomaterials.2009.06.034 ↗
23. Biomaterial-free three-dimensional bioprinting of cardiac tissue using human induced pluripotent stem cell derived cardiomyocytes10.1038/s41598-017-05018-4 ↗
24. Toward engineering functional organ modules by additive manufacturing10.1088/1758-5082/4/2/022001 ↗
25. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform10.3389/fbioe.2016.00012 ↗
26. Evaluation of consistency in spheroid invasion assays10.1038/srep28375 ↗
27. 3D bioprinting of human chondrocyte-laden nanocellulose hydrogels for patient-specific auricular cartilage regeneration10.1016/j.bprint.2016.08.003 ↗
28. Biofabrication of tissue constructs by 3D bioprinting of cell-laden microcarriers10.1088/1758-5082/6/3/035020 ↗
29. Multiparameter analysis of human bone marrow stromal cells identifies distinct immunomodulatory and differentiation-competent subtypes10.1016/j.stemcr.2015.05.005 ↗
30. Synthesis of bioinspired collagen/alginate/fibrin based hydrogels for soft tissue engineering10.1016/j.msec.2018.04.101 ↗
31. Printing apparatus and method
32. Signaling pathways involved in thrombin-induced cell protection10.1074/jbc.273.21.12746 ↗
33. Single-phase liquid jet impingement heat transfer10.1016/S0065-2717(08)70296-X ↗
34. Impingement mixing in reaction injection molding10.1002/pen.760201306 ↗
35. Method of colour recording of information by means of ink jet
36. Rapid formation of a supramolecular polypeptide-DNA hydrogel for in situ three-dimensional multilayer bioprinting10.1002/ange.201411383 ↗
37. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform10.1002/biot.201000340 ↗
38. In-air microfluidics enables rapid fabrication of emulsions, suspensions, and 3D modular (bio)materials10.1126/sciadv.aao1175 ↗
39. Microvalve-based bioprinting—process, bio-inks and applications10.1039/C6BM00861E ↗
40. A comprehensive review on droplet-based bioprinting: past, present and future10.1016/j.biomaterials.2016.06.012 ↗
41. Design and printing strategies in 3D bioprinting of cell-hydrogels: a review10.1002/adhm.201600435 ↗
42. A brief comparison between available bio-printing methods10.1109/GLBC.2015.7158294 ↗
43. Bio-ink properties before, during and after 3D bioprinting10.1088/1758-5090/8/3/032002 ↗
44. Organ bioprinting: are we there yet?10.1002/adhm.201701018 ↗
45. Ozbolat · 2017
46. Laser assisted bioprinting of engineered tissue with high cell density and microscale organization10.1016/j.biomaterials.2010.05.055 ↗
47. High-resolution patterned cellular constructs by droplet-based 3D printing10.1038/s41598-017-06358-x ↗
48. Coaxial extrusion bioprinting of 3D microfibrous constructs with cell-favorable gelatin methacryloyl microenvironments10.1088/1758-5090/aa9d44 ↗
49. Laser-assisted bioprinting at different wavelengths and pulse durations with a metal dynamic release layer: a parametric study10.18063/IJB.2017.01.001 ↗
50. Principles of the Kenzan method for robotic cell spheroid-based three-dimensional bioprinting10.1089/ten.teb.2016.0322 ↗
51. Development of three-dimensional collagen scaffolds with controlled architecture for cell migration studies using breast cancer cell lines10.1016/j.biomaterials.2016.10.048 ↗
52. Modeling tissue morphogenesis and cancer in 3D10.1016/j.cell.2007.08.006 ↗
53. A porous 3D cell culture micro device for cell migration study10.1007/s10544-010-9429-y ↗
54. Fibrin gels and their clinical and bioengineering applications10.1098/rsif.2008.0327 ↗
55. Structural hierarchy governs fibrin gel mechanics10.1016/j.bpj.2010.01.040 ↗
56. 2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells10.1163/156856208786052380 ↗
57. Three-dimensional collagen scaffold promotes intrinsic vascularisation for tissue engineering applications10.1371/journal.pone.0149799 ↗
58. Cell–cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal10.1016/S0014-5793(02)02370-0 ↗
59. Matrix viscoplasticity and its shielding by active mechanics in microtissue models: experiments and mathematical modelling10.1038/srep33919 ↗
60. Capturing complex 3D tissue physiology in vitro10.1038/nrm1858 ↗
61. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues10.1073/pnas.0900174106 ↗
62. Mechanobiology of collective cell behaviours10.1038/nrm.2017.98 ↗
63. 3D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends10.1016/j.gendis.2017.10.002 ↗
64. Controlled differentiation of stem cells10.1016/j.addr.2007.08.036 ↗
65. The mature osteoblast phenotype is characterized by extensive plasticity10.1006/excr.1997.3501 ↗
66. The role of alkaline phosphatase in mineralization10.1097/BCO.0b013e3282630851 ↗
67. Therapeutic implications of PPARgamma in human osteosarcoma10.1155/2010/956427 ↗
68. Mesenchymal stem cells and osteoblast differentiation10.1016/B978-0-12-373884-4.00026-4 ↗
69. High throughput miniature drug-screening platform using bioprinting technology10.1088/1758-5082/4/3/035001 ↗
70. 3D bioprinting for drug discovery and development in pharmaceutics10.1016/j.actbio.2017.05.025 ↗